跳至主要内容
临床试验/IRCT20230727058945N1
IRCT20230727058945N1已完成Unknown

To compare the carotid intima-media thickness in ultrasound of type II diabetic patients with myocardial infarction requiring primary angioplasty in two groups receiving empagliflozin and placebo.

Abidi Pharmaceutical Company0 个研究点目标入组 80 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • type 2 diabetic patients with a history of glucose reducing medications
  • patients with STEMI with ST-segment elevation more than 0.1mv in two or more leads in ECG

排除标准

  • cardiogenic shock
  • hypoglycemia
  • diabetic ketoacidosis
  • history of coronary artery bypass surgery
  • type 1 diabetes
  • severe liver failure
  • advanced cancer patients
  • history of allergy to Empagliflozin or ingredients
  • severe renal failure, ESRD, or dialysis
  • hypovolemia
  • inflammatory diseases
  • Cancer history
  • advanced heart failure
  • patients under 18 years of age

研究者

发起方
Abidi Pharmaceutical Company

相似试验